Northern Trust Corp Spero Therapeutics, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 112,303 shares of SPRO stock, worth $149,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,303

Previous 114,559 1.97%

Holding current value

$149,362

Previous $197,000 26.4%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.27 - $1.8 $2,865 - $4,060	-2,256 Reduced 1.97%	112,303 $145,000
Q1 2024 May 14, 2024	BUY	$1.35 - $1.79 $34,665 - $45,963	25,678 Added 28.89%	114,559 $197,000
Q3 2023 Nov 13, 2023	BUY	$1.2 - $1.63 $163 - $221	136 Added 0.15%	88,881 $107,000
Q2 2023 Aug 11, 2023	BUY	$1.42 - $1.95 $3,534 - $4,853	2,489 Added 2.89%	88,745 $128,000
Q1 2023 May 15, 2023	BUY	$1.35 - $2.0 $22,507 - $33,344	16,672 Added 23.96%	86,256 $125,000
Q4 2022 Feb 13, 2023	SELL	$1.55 - $2.12 $587 - $803	-379 Reduced 0.54%	69,584 $120,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $2.2 $3 - $11	-5 Reduced 0.01%	69,963 $140,000
Q2 2022 Aug 12, 2022	SELL	$0.74 - $7.44 $124,678 - $1.25 Million	-168,484 Reduced 70.66%	69,968 $52,000
Q1 2022 May 13, 2022	SELL	$7.87 - $15.15 $116,066 - $223,432	-14,748 Reduced 5.82%	238,452 $2.07 Million
Q4 2021 Feb 08, 2022	SELL	$13.09 - $18.77 $62,033 - $88,951	-4,739 Reduced 1.84%	253,200 $4.05 Million
Q3 2021 Nov 15, 2021	SELL	$13.03 - $19.51 $38,399 - $57,495	-2,947 Reduced 1.13%	257,939 $4.75 Million
Q2 2021 Aug 13, 2021	BUY	$12.22 - $15.79 $260,383 - $336,453	21,308 Added 8.89%	260,886 $3.64 Million
Q1 2021 May 12, 2021	SELL	$13.23 - $21.48 $349,205 - $566,964	-26,395 Reduced 9.92%	239,578 $3.53 Million
Q4 2020 Feb 11, 2021	BUY	$11.65 - $22.07 $639,538 - $1.21 Million	54,896 Added 26.01%	265,973 $5.16 Million
Q3 2020 Nov 16, 2020	BUY	$8.96 - $14.12 $10,393 - $16,379	1,160 Added 0.55%	211,077 $2.36 Million
Q2 2020 Aug 14, 2020	BUY	$7.27 - $14.18 $339,094 - $661,397	46,643 Added 28.57%	209,917 $2.84 Million
Q1 2020 May 14, 2020	BUY	$5.27 - $10.41 $143,749 - $283,953	27,277 Added 20.06%	163,274 $1.32 Million
Q4 2019 Feb 14, 2020	BUY	$9.46 - $12.16 $150,536 - $193,502	15,913 Added 13.25%	135,997 $1.31 Million
Q3 2019 Nov 13, 2019	BUY	$9.01 - $12.55 $237,269 - $330,491	26,334 Added 28.09%	120,084 $1.27 Million
Q2 2019 Aug 13, 2019	BUY	$10.25 - $14.36 $55,514 - $77,773	5,416 Added 6.13%	93,750 $1.08 Million
Q1 2019 May 13, 2019	SELL	$6.26 - $13.31 $53,203 - $113,121	-8,499 Reduced 8.78%	88,334 $1.13 Million
Q4 2018 Feb 12, 2019	BUY	$5.69 - $11.28 $5,906 - $11,708	1,038 Added 1.08%	96,833 $595,000
Q3 2018 Nov 14, 2018	BUY	$9.69 - $17.79 $282,415 - $518,489	29,145 Added 43.73%	95,795 $1.01 Million
Q2 2018 Aug 14, 2018	BUY	$10.41 - $17.85 $3,029 - $5,194	291 Added 0.44%	66,650 $978,000
Q1 2018 May 09, 2018	BUY	$9.96 - $14.61 $12,290 - $18,028	1,234 Added 1.89%	66,359 $945,000
Q4 2017 Feb 14, 2018	BUY	$10.43 - $14.75 $679,253 - $960,593	65,125	65,125 $765,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

15.5M

Call Options Held

500

Put Options Held

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $46.6M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Spero Therapeutics, Inc. Transaction History